Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
暂无分享,去创建一个
G. Romieu | V. D’Hondt | F. Dalenc | T. Bachelot | E. Pons | W. Jacot | P. Heudel | A. Darlix | S. Thézénas | C. Lévy | S. Guiu | J. Frenel | N. Firmin | V. D'Hondt